.png)
As research continues to support the use of Psychedelics and plant base medicine to potentially treat a range of mental health and behavioral disorders, the success of this growing movement partly depends on the ability of therapy providers to secure insurance coverage. Law360 recently interviewed Eric Rahn for an article entitled "Insuring Psychedelic Therapy Key to Promising Industry." Click here or on the article below:
R&A PSYINS is at the forefront of this new psychedelic movement providing licensed practitioners, ketamine clinics, psychedelic retreats, drug manufacturers and testing facilities with custom Business Liability Insurances. Click here to schedule a consultation with Eric Rahn.